Dalfampridine in the treatment of primary fatigue in patients with multiple sclerosis: a randomized clinical trail.

Shirin MavandadiSepideh PaybastMonirsadat MirzadehHossein Mozhdehipanah

Published in: Acta neurologica Belgica (2024)

The present study revealed a positive short-term effect of extended-release fampridine on MFIS in PwMS. However, this effect was not significantly superior to the placebo.

Keyphrases

sleep quality
depressive symptoms
open label